Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b

Hyoshin Son, Jun-Sang Sunwoo, Sang Kun Lee, Kon Chu, Soon-Tae Lee

Open source

DOI
10.3988/jcn.2021.17.3.428
Published
2021
Container
Journal of Clinical Neurology
Publisher
XMLink
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3988/jcn.2021.17.3.428,
  title = {Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b},
  author = {Hyoshin Son and Jun-Sang Sunwoo and Sang Kun Lee and Kon Chu and Soon-Tae Lee},
  year = {2021},
  journal = {Journal of Clinical Neurology},
  doi = {10.3988/jcn.2021.17.3.428},
  url = {https://doi.org/10.3988/jcn.2021.17.3.428}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b
AU  - Hyoshin Son
AU  - Jun-Sang Sunwoo
AU  - Sang Kun Lee
AU  - Kon Chu
AU  - Soon-Tae Lee
PY  - 2021
JO  - Journal of Clinical Neurology
DO  - 10.3988/jcn.2021.17.3.428
UR  - https://doi.org/10.3988/jcn.2021.17.3.428
ER  - 

APA

Son, H., Sunwoo, J., Lee, S. K., Chu, K., & Lee, S. (2021). Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b. Journal of Clinical Neurology. https://doi.org/10.3988/jcn.2021.17.3.428

Source records